NFE2L2 and cancer: Beyond cancer, NRF2/KEAP1 signaling is critically involved in the pathogenesis of several chronic diseases, including neurodegeneration, metabolic syndrome, and cardiovascular disease, highlighting its dual role in cytoprotection and disease progression [21,22,23].